Burning Rock Biotech Limited reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 563.24 million compared to CNY 507.86 million a year ago. Net loss was CNY 971.23 million compared to CNY 796.7 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.6 USD | -0.78% | -7.65% | -18.28% |
Apr. 02 | Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Revenue $75.7M | MT |
Apr. 02 | Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Loss $-0.90 | MT |
1st Jan change | Capi. | |
---|---|---|
-18.28% | 77.97M | |
-20.70% | 7.83B | |
+67.01% | 4.29B | |
-0.14% | 2.58B | |
-8.23% | 2.48B | |
-38.69% | 2.46B | |
-10.75% | 1.84B | |
-19.84% | 1.53B | |
-40.24% | 1.22B | |
+16.56% | 1.2B |
- Stock Market
- Equities
- BNR Stock
- News Burning Rock Biotech Limited
- Burning Rock Biotech Limited Reports Earnings Results for the Full Year Ended December 31, 2022